Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-04-07
1980-02-19
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112B, 424 12, G01N 3316, A61K 3900, A61B 1000
Patent
active
041894634
ABSTRACT:
The preparation of immunogens and selective antibodies for zoxazolamine therefrom as well as an immunoassay for zoxazolamine using said antibodies is described. Such immunoassay can be utilized to determine an individual's zoxazolamine half-life which has been correlated with the genetically controlled level of benzo[a]pyrene hydroxylase induction. The latter measurement has been associated with risk to carcinoma. Thus, determination of the zoxazolamine half-life by means of the instant immunoassay can be used as a screening test for identifying individuals at special risk to cancer.
REFERENCES:
Conney et al., Fed. Proc., vol. 36, No. 5, Apr. 1977, pp. 1647-1652.
Gould George M.
Hoffmann-La Roche Inc.
Nucker Christine M.
Padgett Benjamin R.
Saxe Jon S.
LandOfFree
Immunoassay for zoxazolamine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassay for zoxazolamine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassay for zoxazolamine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-653235